Filter Results:
(1,326)
Show Results For
- All HBS Web
(1,326)
- People (1)
- News (339)
- Research (812)
- Multimedia (8)
- Faculty Publications (587)
Show Results For
- All HBS Web
(1,326)
- People (1)
- News (339)
- Research (812)
- Multimedia (8)
- Faculty Publications (587)
- June 2009 (Revised June 2009)
- Case
VidaGas: VillageReach - The Mozambican Foundation for Community Development Joint Venture
This case describes the evolution of a liquid petroleum gas (LPG) distributor start-up, incubated by two not-for-profit NGOs to help improve the vaccine cold chain in Northern Mozambique. These NGOs must face the decision whether and how to sell their participation in... View Details
Keywords: Joint Ventures; Supply Chain; Health Care and Treatment; Investment; Non-Governmental Organizations; Energy Sources; Health Industry; Health Industry; Mozambique
Watson, Noel H., and Santiago Kraiselburd. "VidaGas: VillageReach - The Mozambican Foundation for Community Development Joint Venture." Harvard Business School Case 609-107, June 2009. (Revised June 2009.)
- Web
Accounting & Management - Faculty & Research
Accountability ; Leadership ; Change Management ; Mergers and Acquisitions ; Health Industry ; Asia ; India ; Middle East ; United Arab Emirates Citation Related Narayanan, V.G., and Kairavi Dey. "Creating Value By Splitting Aster (B):... View Details
- Web
Research Areas - Doctoral
analysis into practical solutions to real-world problems. 6. Finance researchers strive to understand how managers and firms make value-enhancing decisions; and how financial institutions, markets, and instruments contribute to this... View Details
- 2006
- Working Paper
Can Higher Prices Stimulate Product Use? Evidence from a Field Experiment in Zambia
By: Nava Ashraf, James Berry and Jesse M. Shapiro
The controversy over whether and how much to charge for health products in the developing world rests, in part, on whether higher prices can increase use, either by targeting distribution to high-use households (a screening effect), or by stimulating use... View Details
Ashraf, Nava, James Berry, and Jesse M. Shapiro. "Can Higher Prices Stimulate Product Use? Evidence from a Field Experiment in Zambia." Harvard Business School Working Paper, No. 07-034, December 2006. (Forthcoming, American Economic Review.)
- Web
Class Profile - Doctoral
Pricing Corporate Governance Corporate Strategy Corporate Finance Diversity Emerging Markets Environment Ethics Experimental Economics Game Theory Health Care Incentives Innovation International Business... View Details
- 22 Jul 2014
- First Look
First Look: July 22
August 2013 hfm (Healthcare Financial Management) Using TDABC to Deliver Better Patient Outcomes at Lower Cost By: Kaplan, Robert S. Abstract—No abstract available. Publisher's link: http://www.hfma.org/TDABC August 2013 Accounting Horizons Better Accounting Transforms... View Details
Keywords: Sean Silverthorne
- January 2020
- Case
Celata Bioinnovations
By: John R. Wells and Benjamin Weinstock
In December 2019, Jon Hu (HBS ‘19) and Dr. Samantha Dale Strasser, co-founders of Celata Bioinnovations, were raising $1 million to launch their company. They had founded Celata less than six months earlier with the aim of redefining the drug discovery process.... View Details
Keywords: Drug Development; Drug Discovery; Drug Trials; Pharmaceutical Companies; Pharmaceutical Company; Pharmaceuticals; Therapeutics; Biologics; Biotech; Biotechnology; Biopharmacy Company; Biochemistry; Technology Commercialization; Technology Companies; Drug Testing; Startup; Start-up; Startups; Start-ups; Startup Financing; Strategic Decision Making; Strategic Decisions; Strategic Evolution; FDA; Food And Drug Administration; Clinical Trials; Disease Management; Market Attractiveness; Market Entry; Market Opportunities; Health Disorders; Technological Innovation; Information Technology; Commercialization; Business Startups; Finance; Decision Making; Strategy; Market Entry and Exit; Opportunities; Pharmaceutical Industry; Biotechnology Industry
Wells, John R., and Benjamin Weinstock. "Celata Bioinnovations." Harvard Business School Case 720-427, January 2020.
- Web
Great American Business Leaders of the 20th Century - Leadership
Company, 1955–1966 Robert L. Johnson Black Entertainment Television, 1980–2001 Robert W. Johnson Johnson & Johnson Company, 1885–1910 Jesse H. Jones Reconstruction Finance Corporation, 1933–1939 Reginald H. Jones General Electric Company,... View Details
- April 2023 (Revised July 2023)
- Case
Fermenting Accounting Problems at Vermont Kombucha Corp.
By: Tatiana Sandino and Marshal Herrmann
Founded in 2005, Vermont Kombucha Corp. (V-Ko) was an early mover in the fledgling U.S. market for kombucha, a drink brewed for its health benefits. Early on, the company captured more than 90% of market share. Under the leadership of its founder and CEO, Joe Williams,... View Details
Keywords: Going Public; Business Model; Financial Reporting; Ethics; Corporate Governance; Stock Shares; Food and Beverage Industry
Sandino, Tatiana, and Marshal Herrmann. "Fermenting Accounting Problems at Vermont Kombucha Corp." Harvard Business School Case 123-064, April 2023. (Revised July 2023.)
- Article
Undermining Value-Based Purchasing — Lessons from the Pharmaceutical Industry
By: Leemore S. Dafny, Christopher Ody and Matt Schmitt
The analogy between value-based purchasing in pharmaceuticals and the new frontier of alternative payment models for health care providers is relatively straightforward. Insurers are increasingly demanding steep discounts from providers in exchange for inclusion in... View Details
Keywords: Drug Copayment Coupons; Prescription Drug Policy; Health Care and Treatment; Insurance; Cost; Policy; Pharmaceutical Industry
Dafny, Leemore S., Christopher Ody, and Matt Schmitt. "Undermining Value-Based Purchasing — Lessons from the Pharmaceutical Industry." New England Journal of Medicine 375, no. 21 (November 24, 2016): 2013–2015.
- December 2004 (Revised March 2007)
- Case
Cutlass Capital, L.P.
By: Richard G. Hamermesh and Brian DeLacey
David Hetz and Jon Osgood are forming a new venture capital fund in 2001 to invest in health care start-ups. Describes their fundraising activities at a time when venture capital investing has reached an all-time high. Although their background skills and experiences... View Details
Keywords: Venture Capital; Negotiation Process; Entrepreneurship; Investment Funds; Health Care and Treatment; Business Startups; Health Industry; United States
Hamermesh, Richard G., and Brian DeLacey. "Cutlass Capital, L.P." Harvard Business School Case 805-075, December 2004. (Revised March 2007.)
- December 2010
- Article
Can Higher Prices Stimulate Product Use? Evidence from a Field Experiment in Zambia
By: Nava Ashraf, James Berry and Jesse M. Shapiro
The controversy over how much to charge for health products in the developing world rests, in part, on whether higher prices can increase use, either by targeting distribution to high-use households (a screening effect), or by stimulating use psychologically through a... View Details
Ashraf, Nava, James Berry, and Jesse M. Shapiro. "Can Higher Prices Stimulate Product Use? Evidence from a Field Experiment in Zambia." American Economic Review 100, no. 5 (December 2010): 2383–2413. (Online Appendix.)
- December 1999 (Revised August 2001)
- Case
Millennium Pharmaceuticals, Inc. (A)
By: Stefan H. Thomke and Ashok Nimgade
Focuses on Millennium's strategy to grow and revolutionize drug development through the use of new technologies such as genomics. Describes how Millennium Pharmaceuticals--a fast-growing biotechnology firm in Cambridge, MA--has used strategic alliances to finance the... View Details
Keywords: Cost Management; Financing and Loans; Medical Specialties; Retention; Growth and Development Strategy; Time Management; Product Development; Problems and Challenges; Alliances; Technology; Biotechnology Industry; Pharmaceutical Industry; Cambridge
Thomke, Stefan H., and Ashok Nimgade. "Millennium Pharmaceuticals, Inc. (A)." Harvard Business School Case 600-038, December 1999. (Revised August 2001.)
- June 2012
- Case
GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships
By: Arthur A. Daemmrich and Ian McKown Cornell
Three years into a major public-private partnership between GlaxoSmithKline and Fiocuz, Brazil's principal health institute, the company assesses technology transfer and joint research under the agreement. GSK was selling its Synflorix vaccine (against pediatric... View Details
Keywords: Public-Private Partnerships; Business and Government Relations; Foreign Direct Investment; Health Care and Treatment; Globalized Firms and Management; Biotechnology Industry; Pharmaceutical Industry; Brazil
Daemmrich, Arthur A., and Ian McKown Cornell. "GlaxoSmithKline in Brazil: Public-Private Vaccine Partnerships." Harvard Business School Case 712-049, June 2012.
- August 1998
- Case
Record Masters
By: William A. Sahlman, Michael J. Roberts and Laurence E. Katz
Kent Dauten, a former general partner at the Chicago private equity firm of Madison Dearborn Partners, has engaged in a search to personally sponsor a buyout in which he can play an active management role. He has received a selling memorandum for Record Masters, a... View Details
Sahlman, William A., Michael J. Roberts, and Laurence E. Katz. "Record Masters." Harvard Business School Case 899-020, August 1998.
- Web
Named Fellowship Funds - Alumni
1967) in honor of Gerald's 50th Reunion. Darlene is the executive director of the Gerald R. Jordan Jr. Foundation, which supports education, health and medical research, youth services, and the arts. She served as national View Details
- Web
Technology & Operations Management - Faculty & Research
Variation in Batch Ordering of Imaging Tests in the Emergency Department and the Impact on Care Delivery By: Jacob C. Jameson, Soroush Saghafian, Robert S. Huckman and Nicole Hodgson February 2025 | Article | Health Services Research... View Details
- Web
Podcast - Business & Environment
of the Voluntary Carbon Markets Integrity Initiative (VCMI). Mark has worked in carbon markets and climate finance for nearly three decades, with experience at organizations like WWF, The Climate Group, and Fundación Natura in Ecuador.... View Details
- 2013
- Working Paper
Asset Accumulation and Labor Force Participation of Disability Insurance Applicants
By: Pian Shu
Using panel data from the RAND Health and Retirement Study, I show that rejected applicants for Social Security Disability Insurance (SSDI) possess significantly more assets immediately prior to their application and exhibit lower labor force attachment than accepted... View Details
Keywords: Disability Insurance; Asset Accumulation; Labor Force Participation; Assets; Behavior; Employment; Insurance; Insurance Industry; United States
Shu, Pian. "Asset Accumulation and Labor Force Participation of Disability Insurance Applicants." Harvard Business School Working Paper, No. 14-008, July 2013.
- Article
Operational Efficiency and Effective Management in the Catheterization Laboratory
By: Grant W. Reed, Michael L. Tushman and Samir R. Kapadia
Operational efficiency is a core business principle in which organizations strive to deliver high-quality goods or services in a cost-effective manner. This concept has become increasingly relevant to cardiac catheterization laboratories, as insurers move away from... View Details
Keywords: Cath Lab; Catheterization Laboratory; Health Care and Treatment; Performance Efficiency; Management; Performance Productivity; Cost Management; Health Industry
Reed, Grant W., Michael L. Tushman, and Samir R. Kapadia. "Operational Efficiency and Effective Management in the Catheterization Laboratory." Journal of the American College of Cardiology 72, no. 20 (November 20, 2018): 2507–2517.